01 Natural and clean-label formulations gaining groundPet owners are increasingly seeking calming products that emphasise natural, safe ingredients rather than heavy pharmaceuticals. Pet owners are willing to pay more for products with claims of organic, holistic, or non-sedative support for pets’ emotional wellness.For example, in October 2025, Zesty Paws introduced a calming diffuser for cats that uses a natural, drug-free formula to emit feline-specific pheromones, marking a shift from ingestible supplements to ambient calming technology.Overall, the demand for natural and clean-label formulations is shaping product development, distribution, and marketing, enabling companies to differentiate via premium ingredients and holistic wellness positioning.
02 Integration of smart tech-enabled calming solutionsThe pet calming market is expanding toward technology-based solutions that monitor or actively intervene in pet stress or anxiety. These innovations help pet owners to supply calming products, track pet behaviour and intervene in real time. As the pet care industry becomes more sophisticated, tech-enabled calming solutions are differentiating on data, connectivity, and holistic wellness integration. This trend aligns with broader human wellness trends and positions the pet calming market to evolve from commodity treats to smart wellness ecosystems.
01 Rising pet ownership and premium pet care spendingThe calming products market is strongly driven by pet humanisation globally. Companion animal ownership is rising, especially in urban centres, where households increasingly view pets as family members. This shift expands consumer spending beyond basic care to premium pet wellness, focusing specifically on emotional and behavioural support. As pets face more stress-related triggers due to urban living, travel, noise, etc., the market shows significant growth.Moreover, the intersection of higher pet ownership, wellness consciousness, and willingness to spend on emotional and behavioural pet support drives the market consistently.
01 Limited clinical validation and consumer trust concernsOne major restraint in the pet calming products market is that many products rely on natural ingredients, supplements or behavioural claims rather than standardised clinical trials. Pet owners and veterinarians may question efficacy, dosage, safety and regulatory compliance. The variability in regulatory oversight further complicates trust. Due to this, some pet owners may postpone purchase or rely solely on veterinary prescriptions or trusted brands, which slows mass-market adoption.
01 Expansion in emerging marketEmerging markets in the Asia Pacific and Latin America offer significant growth opportunities for pet calming products. The rising urbanisation, increasing pet ownership, rising disposable incomes, greater awareness of pet wellness and expansion of e-commerce platforms in these regions support the market’s development. Manufacturers and retailers that establish strong distribution and localised product offerings tailored for local breeds, price points and language can tap large incremental growth. Many US-centric brands are expanding globally to build an early presence in Asia.
March 2026 Zoetis expanded its companion animal wellness portfolio by introducing new behavioral health solutions designed to support stress management and overall well-being in pets.
September 2025 Nestlé Purina PetCare launched new calming nutrition products under its pet wellness portfolio, incorporating functional ingredients to support relaxation and emotional balance in dogs and cats.
May 2025 Virbac introduced new pet behavioral care products focused on reducing anxiety and stress-related issues, strengthening its position in the companion animal health market.